DLBCL (Diffuse Large B Cell Lymphoma),FL (Follicular Lymphoma),Lymphoma,MCL (Mantle Cell Lymphoma),MZL (Marginal Zone Lymphoma)
Subcutaneous Epcoritamab Is Well-Tolerated And Effective In Patients With R/R LBCL
DLBCL (Diffuse Large B Cell Lymphoma),FL (Follicular Lymphoma),Lymphoma,MCL (Mantle Cell Lymphoma),MZL (Marginal Zone Lymphoma)
Epcoritamab Shows Lasting Remissions in R/R LBCL Patients
Sign up for our emails
Trusted insights straight to your inbox and get the latest updates from OncWeekly